The -149C>T SNP within the ΔDNMT3B gene, is not associated with early disease onset in hereditary non-polyposis colorectal cancer

Cancer Letters

Volumn 265, Issue 1, 2008, Pages 39-44

  Reeves, S G ^a   Mossman, D ^a   Meldrum, C J ^b   Kurzawski, G ^c   Suchy, J ^c   Lubinski, J ^c   Scott, R J ^a,b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b JOHN HUNTER HOSPITAL   (Australia)

^c International Hereditary Cancer Center   (Poland)

Author keywords

Disease expression; DNMT3B; Epidemiology; Hereditary non polyposis colorectal cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; COLORECTAL CANCER; DNMT3B GENE; FEMALE; GENE; GENE MUTATION; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS;

EID: 43449128387     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.02.005     Document Type: Article

References (13)

1. Lynch H.T., Smyrk T.C., Watson P., Lanspa S.J., Lynch J.F., Lynch P.M., Cavalieri R.J., and Boland C.R. Genetics, natural history, tumour spectrum, and pathology of hereditary nonpolyposis colorectal cancer: and updated review. Gastroenterology 104 5 (1993) 1535-1549
2. Lynch H.T., and de la Chapelle A. Genetic susceptibility to non-polyposis colorectal cancer. Journal of Medical Genetics 36 (1999) 801-818
3. Aarnio M., Sankila R., Pukkala E., Salovaara R., Aaltonen L.A., de la Chapelle A., Peltomaki P., Mecklin J.P., and Jarvinen H.J. Cancer risk in mutation carriers of DNA-mismatch repair genes. International Journal of Cancer 81 2 (1999) 214-218
4. Thibodeau S.N., Bren G., and Schaid D. Microsatellite instability in cancer of the proximal colon. Science 260 (1993) 816-819
5. Morgan H.D., Santos F., Green K., Dean W., and Reik W. Epigenetic reprogramming in mammals. Human Molecular Genetics 1 14 review issue (2005) r47-r58
6. Melki J.R., Warnecke P., Vincent P.C., and Clark S.J. Increased DNA methyltransferase expression in leukemia. Leukemia 12 3 (1998) 311-316
7. Jin F., Dowdy S.C., Xiong Y., Eberhardt N.L., Podratz K.C., and Jiang S.W. Up-regulation of DNA methyltransferase 3B expression in endometrial cancers. Gynaecological Oncology 96 2 (2005) 531-538
8. Belinsky S.A., Nikula K.J., Baylin S.B., and Issa J.P. Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer. Proceedings of the National Academy of Science, USA 93 9 (1996) 4045-4050
9. Schmutte C., Yang A.S., Nguyen T.T., Beart R.W., and Jones P.A. Mechanisms for the involvement of the DNA methylation in colon carcinogenesis. Cancer Research 56 (1996) 2375-2381
10. Wang L., Wang J., Sun S., Rodriguez M., Yue P., Jang S.J., and Mao L. A Novel DNMT3B subfamily, ΔDNMT3B, is the predominant form of DNMT3B in non-small cell lung cancer. International Journal of Oncology 29 (2006) 201-207
11. Wang L., Rodriguez M., Kim E.S., Xu Y., Bekele N., El-Naggar A.K., Hong W.K., Mao L., and Oh Y.W. A Novel C/T polymorphism in the core promoter of human de novo cytosine DNA methyltransferase 3B6 is associated with prognosis in head and neck cancer. International Journal of Oncology 25 4 (2004) 993-999
12. Jones J.S., Amos C.I., Pande M., Gu Z., Chen J., Campos I.M., Wei Q., Rodriguez-Bigas M., Lynch P.M., and Frazier M.L. DNMT3b polymorphism and hereditary nonpolyposis colorectal cancer age of onset. Cancer Epidemiology Biomarkers and Prevention 15 5 (2006) 886-889
13. Shen H., Wang L., Spitz M.R., Hong W.K., Mao L., and Wei Q. A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer. Cancer Research 62 (2002) 4992-4995